Member- May 8, 2012
- 1,601
- Tinnitus Since
- 04/15/2012 or earlier?
- Cause of Tinnitus
- Most likely hearing loss
Research news a bit thin the past couple of months so this is welcomed news.....
December 5, 2012
The National Institute on Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health has awarded $1.47 million to Northeast Ohio Medical University (NEOMED) in support of Alexander V. Galazyuk, Ph.D., associate professor of anatomy and neurobiology in the NEOMED College of Medicine, for his research of tinnitus, or noise/ringing in the ears.
According to the NIDCD, in the past year, experts estimate that 22.7 million adult Americans experienced tinnitus for more than three months—about 10 percent of the adult population of the United States. Dr. Galazyuk's research on the neural mechanisms underlying sound-evoked suppression of tinnitus is designed to improve knowledge of the mechanisms responsible for tinnitus and provide a foundation for the development of therapeutic drugs to treat tinnitus.
"Tinnitus can be suppressed briefly following the offset of an external sound through a phenomenon known as 'residual inhibition,' although its underlying cellular mechanism remains unknown," said Jeffrey J. Wenstrup, Ph.D., chair of the Department of Anatomy and Neurobiology. "This new grant will allow Dr. Galazyuk to continue his research on the mechanism responsible for residual inhibition in order to identify a class of drugs that can either prolong residual inhibition or suppress tinnitus without the application of any external sounds."
Research from Dr. Galazyuk's lab to date has found that a loud, long-lasting sound stimulus can suppress spontaneous firing in central auditory neurons for as long as the duration of residual inhibition. Abnormally high spontaneous firing has been linked to behavioral manifestations of tinnitus; therefore, suppression of this firing is a plausible candidate for the underlying mechanism of residual inhibition. This hypothesis will be tested as part of the research supported by the NIDCD grant, of which Dr. Galazyuk has now received two installments.
"Dr. Galazyuk's work on tinnitus is a crucial component of the University's auditory neuroscience research focus area, which promotes excellence in hearing research as well as related disciplines such as communication, clinical audiology, clinical neuroscience and biotechnology," said Walter E. Horton Jr., vice president for research and dean for the College of Graduate Studies at NEOMED. "His efforts, in collaboration with the other exceptional researchers in this focus area, are generating a great deal of attention and recognition of our University's expertise in this area of research."The National Institute on Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health has awarded $1.47 million to Northeast Ohio Medical University (NEOMED) in support of Alexander V. Galazyuk, Ph.D., associate professor of anatomy and neurobiology in the NEOMED College of Medicine, for his research of tinnitus, or noise/ringing in the ears.
According to the NIDCD, in the past year, experts estimate that 22.7 million adult Americans experienced tinnitus for more than three months—about 10 percent of the adult population of the United States. Dr. Galazyuk's research on the neural mechanisms underlying sound-evoked suppression of tinnitus is designed to improve knowledge of the mechanisms responsible for tinnitus and provide a foundation for the development of therapeutic drugs to treat tinnitus.
"Tinnitus can be suppressed briefly following the offset of an external sound through a phenomenon known as 'residual inhibition,' although its underlying cellular mechanism remains unknown," said Jeffrey J. Wenstrup, Ph.D., chair of the Department of Anatomy and Neurobiology. "This new grant will allow Dr. Galazyuk to continue his research on the mechanism responsible for residual inhibition in order to identify a class of drugs that can either prolong residual inhibition or suppress tinnitus without the application of any external sounds."
Research from Dr. Galazyuk's lab to date has found that a loud, long-lasting sound stimulus can suppress spontaneous firing in central auditory neurons for as long as the duration of residual inhibition. Abnormally high spontaneous firing has been linked to behavioral manifestations of tinnitus; therefore, suppression of this firing is a plausible candidate for the underlying mechanism of residual inhibition. This hypothesis will be tested as part of the research supported by the NIDCD grant, of which Dr. Galazyuk has now received two installments.
"Dr. Galazyuk's work on tinnitus is a crucial component of the University's auditory neuroscience research focus area, which promotes excellence in hearing research as well as related disciplines such as communication, clinical audiology, clinical neuroscience and biotechnology," said Walter E. Horton Jr., vice president for research and dean for the College of Graduate Studies at NEOMED. "His efforts, in collaboration with the other exceptional researchers in this focus area, are generating a great deal of attention and recognition of our University's expertise in this area of research."
Dr. Galazyuk joined the Department of Anatomy and Neurobiology at NEOMED in 2003. He earned a Master of Science degree in human and animal physiology from Kiev State University and a Doctor of Philosophy degree in physiology from the A.A. Bogomoletz Institute of Physiology, both in Kiev, Ukraine.
Dr. Galazyuk joined the Department of Anatomy and Neurobiology at NEOMED in 2003. He earned a Master of Science degree in human and animal physiology from Kiev State University and a Doctor of Philosophy degree in physiology from the A.A. Bogomoletz Institute of Physiology, both in Kiev, Ukraine.
December 5, 2012
The National Institute on Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health has awarded $1.47 million to Northeast Ohio Medical University (NEOMED) in support of Alexander V. Galazyuk, Ph.D., associate professor of anatomy and neurobiology in the NEOMED College of Medicine, for his research of tinnitus, or noise/ringing in the ears.
According to the NIDCD, in the past year, experts estimate that 22.7 million adult Americans experienced tinnitus for more than three months—about 10 percent of the adult population of the United States. Dr. Galazyuk's research on the neural mechanisms underlying sound-evoked suppression of tinnitus is designed to improve knowledge of the mechanisms responsible for tinnitus and provide a foundation for the development of therapeutic drugs to treat tinnitus.
"Tinnitus can be suppressed briefly following the offset of an external sound through a phenomenon known as 'residual inhibition,' although its underlying cellular mechanism remains unknown," said Jeffrey J. Wenstrup, Ph.D., chair of the Department of Anatomy and Neurobiology. "This new grant will allow Dr. Galazyuk to continue his research on the mechanism responsible for residual inhibition in order to identify a class of drugs that can either prolong residual inhibition or suppress tinnitus without the application of any external sounds."
Research from Dr. Galazyuk's lab to date has found that a loud, long-lasting sound stimulus can suppress spontaneous firing in central auditory neurons for as long as the duration of residual inhibition. Abnormally high spontaneous firing has been linked to behavioral manifestations of tinnitus; therefore, suppression of this firing is a plausible candidate for the underlying mechanism of residual inhibition. This hypothesis will be tested as part of the research supported by the NIDCD grant, of which Dr. Galazyuk has now received two installments.
"Dr. Galazyuk's work on tinnitus is a crucial component of the University's auditory neuroscience research focus area, which promotes excellence in hearing research as well as related disciplines such as communication, clinical audiology, clinical neuroscience and biotechnology," said Walter E. Horton Jr., vice president for research and dean for the College of Graduate Studies at NEOMED. "His efforts, in collaboration with the other exceptional researchers in this focus area, are generating a great deal of attention and recognition of our University's expertise in this area of research."The National Institute on Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health has awarded $1.47 million to Northeast Ohio Medical University (NEOMED) in support of Alexander V. Galazyuk, Ph.D., associate professor of anatomy and neurobiology in the NEOMED College of Medicine, for his research of tinnitus, or noise/ringing in the ears.
According to the NIDCD, in the past year, experts estimate that 22.7 million adult Americans experienced tinnitus for more than three months—about 10 percent of the adult population of the United States. Dr. Galazyuk's research on the neural mechanisms underlying sound-evoked suppression of tinnitus is designed to improve knowledge of the mechanisms responsible for tinnitus and provide a foundation for the development of therapeutic drugs to treat tinnitus.
"Tinnitus can be suppressed briefly following the offset of an external sound through a phenomenon known as 'residual inhibition,' although its underlying cellular mechanism remains unknown," said Jeffrey J. Wenstrup, Ph.D., chair of the Department of Anatomy and Neurobiology. "This new grant will allow Dr. Galazyuk to continue his research on the mechanism responsible for residual inhibition in order to identify a class of drugs that can either prolong residual inhibition or suppress tinnitus without the application of any external sounds."
Research from Dr. Galazyuk's lab to date has found that a loud, long-lasting sound stimulus can suppress spontaneous firing in central auditory neurons for as long as the duration of residual inhibition. Abnormally high spontaneous firing has been linked to behavioral manifestations of tinnitus; therefore, suppression of this firing is a plausible candidate for the underlying mechanism of residual inhibition. This hypothesis will be tested as part of the research supported by the NIDCD grant, of which Dr. Galazyuk has now received two installments.
"Dr. Galazyuk's work on tinnitus is a crucial component of the University's auditory neuroscience research focus area, which promotes excellence in hearing research as well as related disciplines such as communication, clinical audiology, clinical neuroscience and biotechnology," said Walter E. Horton Jr., vice president for research and dean for the College of Graduate Studies at NEOMED. "His efforts, in collaboration with the other exceptional researchers in this focus area, are generating a great deal of attention and recognition of our University's expertise in this area of research."
Dr. Galazyuk joined the Department of Anatomy and Neurobiology at NEOMED in 2003. He earned a Master of Science degree in human and animal physiology from Kiev State University and a Doctor of Philosophy degree in physiology from the A.A. Bogomoletz Institute of Physiology, both in Kiev, Ukraine.
Dr. Galazyuk joined the Department of Anatomy and Neurobiology at NEOMED in 2003. He earned a Master of Science degree in human and animal physiology from Kiev State University and a Doctor of Philosophy degree in physiology from the A.A. Bogomoletz Institute of Physiology, both in Kiev, Ukraine.
